Lowenstein Sandler LLP acted as US counsel Edesa Biotech, Inc., Fasken Martineau DuMoulin, LLP, Canadian local counsel for the Company, Fenwick & West LLP, intellectual property...
Edesa Biotech Closes $25 Million Public Offering of Shares and Warrants
Matinas BioPharma and GH Power Announce Business Combination to Create NYSE-listed Clean Energy and Critical Minerals Company
Lowenstein Sandler LLP has represented Matinas BioPharma Holdings, Inc. in its business combination agreement with GH Power, Inc. Matinas BioPharma Holdings, Inc., a biopharmaceutical company listed...
Azurity Pharmaceuticals to Acquire Matinas BioPharma Nanotechnologies
Lowenstein has advised Matinas in the sale of Matinas BioPharma Nanotechnologies to Azurity Pharmaceuticals. Matinas BioPharma has entered into a definitive stock purchase agreement to sell...
Sonnet BioTherapeutics Completes Business Combination with Hyperliquid Strategies
Lowenstein Sandler has advised Sonnet BioTherapeutics Holdings. Greenberg Traurig has advised Hyperliquid Strategies Inc. Sonnet BioTherapeutics Holdings, an oncology-focused biotechnology company, has completed its business combination...
Relmada Therapeutics Announces $100 Million Underwritten Offering
Lowenstein Sandler has advised Relmada Therapeutics. Holland & Hart has advised the book-running managers. Relmada Therapeutics, a clinical-stage biotechnology company listed on Nasdaq under the symbol...
Sonnet BioTherapeutics and Rorschach I LLC Announce $888 Million HYPE Cryptocurrency Treasury Reserve Strategy
Lowenstein Sandler LLP has advised Sonnet BioTherapeutics, Inc. Greenberg Traurig, LLP has represented Rorschach I LLC. Sonnet BioTherapeutics, Inc. has entered into a definitive agreement to...
Sonnet BioTherapeutics’ $5 Million Common Stock Offering
Lowenstein Sandler advised Sonnet BioTherapeutics, while Sullivan & Worcester advised Chardan Capital Markets on the offering. Sonnet BioTherapeutics Holdings, Inc. (Nasdaq: SONN), a clinical-stage company developing...
Dragonfly Energy’s $30 Million Licensing Agreement for Battle Born Batteries Brand with Stryten Energy
Lowenstein Sandler represented Dragonfly Energy Holdings Corp. in the transaction. Dragonfly Energy Holdings Corp. (Nasdaq: DFLI), an industry leader in energy storage and manufacturer of lithium-ion...
Applied Digital’s Private Debt Facility to Accelerate North Dakota Data Center Project
Lowenstein Sandler represented Applied Digital Corporation in the transaction. Applied Digital Corporation (NASDAQ: APLD) announced the closing of a $125 million loan to fund the company’s...
ZOOZ Power’s Business Combination with Keyarch Acquisition Corporation
Lowenstein Sandler, Shibolet & Co. and Maples Group represented ZOOZ Power Ltd. in the transaction. Goldfarb Gross Seligman & Co., Ellenoff Grossman & Schole and Walkers...
Timber Pharmaceuticals’ Chapter 11 and Asset Sale to Leo Pharma
Lowenstein Sandler represented Timber Pharmaceuticals, Inc. in the transaction. Timber Pharmaceuticals, Inc. (NYSE: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for...
Corbus Pharmaceuticals’ $94.5 Million Shares Public Offering
Lowenstein Sandler represented Corbus Pharmaceuticals Holdings, Inc. in the transaction. Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a precision oncology company with a diversified portfolio, announced the...